The World Health Organization (WHO) released updated consolidated guidelines on treatment of drug-susceptible TB (DS-TB) including a new recommendation for the use of a 4-month regimen composed of isoniazid, rifapentine, moxifloxacin and pyrazinamid.
The guidelines are complemented by an operational handbook designed to assist the implementation of WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DS-TB.
For further information, click here.
For more TB news, check out the latest edition of the TB Online Weekly Newsletter (#18, 31 May 2022).
Source : World Health Organization
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.